mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.1 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |